Teleflex Acquires Semprus BioSciences for $30,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7fe1a948-a8fe-453f-9830-25c9c60d4bfe&Preview=1 -
Date
6/26/2012 -
Company Name
Semprus BioSciences -
Mailing Address
One Kendall Street Building 1400 1st Floor Cambridge, MA 02139 -
Company Description
Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications. Our initial product development efforts are focused on the first implantable and permanently antimicrobial surface technology. The intellectual property comes from the MIT labs of Prof. Robert Langer and Prof. Greg Stephanopoulos, and part of this scientific research was featured in Nature. -
Website
http://www.semprusbio.com -
Transaction Type
M&A -
Transaction Amount
$30,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Teleflex paid $30 million upfront for Semprus, in additional to potential milestones, which were not disclosed.
